Interim estimates of 2017–18 seasonal influenza vaccine effectiveness — United States, February 2018

American Journal of Transplantation

Volumn 18, Issue 4, 2018, Pages 1020-1025

  Flannery, Brendan ^a   Chung, Jessie R ^a   Belongia, Edward A ^b   McLean, Huong Q ^b   Gaglani, Manjusha ^c   Murthy, Kempapura ^c   Zimmerman, Richard K ^d   Nowalk, Mary Patricia ^d   Jackson, Michael L ^e   Jackson, Lisa A ^e   Monto, Arnold S ^f   Martin, Emily T ^f   Foust, Angie ^a   Sessions, Wendy ^a   Berman, LaShondra ^a   Barnes, John R ^a   Spencer, Sarah ^a   Fry, Alicia M ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b MARSHFIELD CLINIC   (United States)

^c TEXAS A M COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e KAISER PERMANENTE   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85044651705     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.14730     Document Type: Article

References (10)

1. Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2017–18 influenza season. MMWR Recomm Rep. 2017;66(No. RR-2).
2. Jackson ML, Chung JR, Jackson LA, et al. Influenza vaccine effectiveness in the United States during the 2015–2016 season. N Engl J Med. 2017;377:534-543.
3. Budd AP, Wentworth DE, Blanton L, et al. Update: influenza activity—United States, October 1, 2017–February 3, 2018. MMWR Morb Mortal Wkly Rep. 2018;67:169-179.
4. Skowronski DM, Chambers C, De Serres G, et al. Early season co-circulation of influenza A(H3N2) and B(Yamagata): Interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018. Euro Surveill. 2018;23
5. Sullivan SG, Chilver MB, Carville KS, et al. Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017. Euro Surveill. 2017;22
6. Flannery B, Chung JR, Thaker SN, et al. Interim estimates of 2016–17 seasonal influenza vaccine effectiveness—United States, February 2017. MMWR Morb Mortal Wkly Rep. 2017;66:167-171.
7. Belongia EA, Simpson MD, King JP, et al. Variable influenza vaccine effectiveness by subtype: A systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis. 2016;16:942-951.
8. Zost SJ, Parkhouse K, Gumina ME, et al. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc Natl Acad Sci U S A. 2017;114:12578-12583.
9. Wu NC, Zost SJ, Thompson AJ, et al. A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. PLoS Pathog. 2017;13:e1006682.
10. Fry AM, Kim IK, Reed C, et al. Modeling the effect of different vaccine effectiveness estimates on the number of vaccine-prevented influenza-associated hospitalizations in older adults. Clin Infect Dis. 2014;59:406-409.